Drug Shortage Report for DESFERAL 500MG
| Report ID | 191074 |
| Drug Identification Number | 01981242 |
| Brand name | DESFERAL 500MG |
| Common or Proper name | DESFERAL 500MG |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEFEROXAMINE MESYLATE |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR |
| Packaging size | 1 X 10 |
| ATC code | V03AC |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-05-15 |
| Actual start date | |
| Estimated end date | 2023-09-18 |
| Actual end date | 2023-09-29 |
| Shortage status | Resolved |
| Updated date | 2023-10-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-10-04 | French | Compare |
| v6 | 2023-10-04 | English | Compare |
| v5 | 2023-06-20 | French | Compare |
| v4 | 2023-06-20 | English | Compare |
| v3 | 2023-05-16 | English | Compare |
| v2 | 2023-04-28 | French | Compare |
| v1 | 2023-04-28 | English | Compare |
Showing 1 to 7 of 7